X4 Pharmaceuticals Quote - XFOR

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.6604

Bid

0.6604

Offer

0.69

Volume

396,865

0.6573 Day's Range 0.6899

0.5311 52 Week Range 6.18

Market Cap

111.277M

Previous Close

0.69

Open

0.6714

Last Trade

0.69

Last Trade Time

Financial Volume

US$ 267,870

VWAP

0.674965

Average Volume (3m)

2,593,576

Shares Outstanding

168,499,514

Dividend Yield

PE Ratio

-1.13

Earnings Per Share (EPS)

-0.6

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.69. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.5311 to US$ 6.18.

X4 Pharmaceuticals currently has 168,499,514 shares in issue. The market capitalisation of X4 Pharmaceuticals is US$116.26 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.13.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0362	5.79942326178	0.6242	0.785	0.5815	857585	0.69607663	CS
4	-0.2896	-30.4842105263	0.95	1.04	0.5311	2008771	0.68522565	CS
12	-0.2396	-26.6222222222	0.9	1.6	0.5311	2593576	1.00695708	CS
26	-0.5596	-45.868852459	1.22	1.6	0.5311	2203270	0.93459058	CS
52	-4.2696	-86.6044624746	4.93	6.18	0.5311	1576800	1.32026888	CS
156	-13.6696	-95.3914863922	14.33	15.95	0.5311	977345	1.62287059	CS
260	0	0	0	0.6985	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CNEYCN Energy Group Inc	US$ 1.37 (359.42%)	347.17M
FTCIFTC Solar Inc	US$ 0.448 (99.02%)	283.39M
PLCEChildrens Place Inc	US$ 9.09 (85.51%)	73.38M
SPISPI Energy Company Ltd	US$ 0.545 (78.10%)	19.29M
ADDColor Star Technology Company Ltd	US$ 0.9425 (44.98%)	4.24M
TBIOTelesis Bio Inc	US$ 1.70 (-55.26%)	245.76k
LASELaser Photonics Corporation	US$ 5.4337 (-40.62%)	4.17M
MDJHMDJM Ltd	US$ 0.685 (-37.15%)	512.11k
FAASDigiAsia Corporation	US$ 1.16 (-27.50%)	145.92k
BFIBurgerFi International Inc	US$ 0.1419 (-21.99%)	5.69M
NVDANVIDIA Corporation	US$ 116.91 (8.15%)	441.36M
CNEYCN Energy Group Inc	US$ 1.37 (359.42%)	347.17M
FTCIFTC Solar Inc	US$ 0.448 (99.02%)	283.39M
SQQQProShares UltraPro Short QQQ	US$ 8.53 (-6.47%)	266.37M
TANHTantech Holdings Ltd	US$ 0.1753 (26.66%)	217.52M